| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824752 | Clinical Therapeutics | 2015 | 13 Pages |
Abstract
Overall, daptomycin was effective and well tolerated for VRE bacteremia, with lower effectiveness noted with daptomycin MIC of 3 to 4 µg/mL. Concomitant β-lactam therapy with daptomycin may improve clinical outcomes in this setting. Further studies are needed to characterize the potential benefit of concomitant β-lactams with daptomycin.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Pamela A. PharmD, George MD, James A. MD, Kenneth C. PharmD, Daryl D. PharmD, Min J. MPH, Katherine MD, Marcus J. MD,